Hang Zhang Yuwei / Xinhua / Getty Images
Beijing, March 16, 2020. A staff member on March 16, 2020, in the Chinese capital, Beijing, called SinoWak Biotech Ltd. Displaying samples of COVID-19 inactivated vaccine at. China approved two COVID-19 inactivated vaccine candidates for clinical trials, according to the State Council’s joint prevention and control mechanism against coronavirus on Tuesday. Candidates for the two vaccines are China National Pharmaceutical Group, Wuhan Institute BiF Biological Products under Synopharm and Synovac Research and Development Co., a Beijing-based company. Developed by Ltd. Clinical trials of two vaccines have begun. (Photo by Getty by Zenti Yuwei / Xinhua) (Xinhua / Zhang Yuwei by Getty Images)
About one million people have been vaccinated with the experimental coronavirus by Synopharm as part of an emergency-use program authorized by Beijing, said the chairman of the Chinese pharmaceutical giant.
No serious adverse effects have yet been reported from vaccine recipients, Sinofarm said, quoting chairman Liu Jingzen in an article on social media platform WeChat on Wednesday.
“In emergency use, we have now used it on about one million people. We have not received any reports of serious adverse reactions, and only a few people have some mild symptoms,” Liu said.
Liu said the vaccine was given to Chinese construction workers, diplomats and students who have traveled to more than 150 countries during the epidemic – and none of them have been infected.
He said in November that there were 1,000 emergency people who received emergency vaccines and then went abroad.
“For example, an international company has 99 employees in its overseas office fees, out of which vacc1 was vaccinated. And later, an outbreak in office fees, 10 out of 18 people not vaccinated became infected and none of them were vaccinated. , ”He said.
Video: Expert: Pfizer vaccine ‘very good news’ (CNN)
Click to enlarge
Now the next
Separately, Sinofarm conducted Phase 3 clinical trials involving about 60,000 people from 10 countries, including the UAE, Bahrain, Egypt, Jordan, Peru and Argentina, he said. CNN has not yet seen the results of these tests.
Sinofarm has two vaccine candidates. It is unclear which vaccine Lu referred to
Beijing has been approving companies for immediate vaccinations using experimental drugs for months. In June, Chinese company Cancino Biologics announced that it had been given the exclusive right to give its experimental vaccine to the People’s Liberation Army.
Since July, Chinese drug manufacturers have been offering experimental vaccines to people working in “high-risk” occupations under the Emergency Use program, allowing vaccine candidates to use them on a limited basis before fully proving their safety and effectiveness through clinical trials. .
Experimental coronavirus vaccines have also been made public in some parts of China, causing some citizens to rush across the country to get their hands on the dose.
It came after Pfizer announced the results of its Phase 3 coronavirus vaccine tests on Wednesday, which it said were 95% effective in preventing infection – even in the elderly – and because there were no serious safety concerns. A day earlier, Moderna announced that its coronavirus vaccine is 94.5% effective.
Pfizer on Friday traveled to the U.S. for his vaccine. The Food and Drug Administration is expected to approve the emergency use.
Dr. Anthony Fauci, a top infectious disease specialist in the U.S., said the Pfizer and Moder vaccines have shown exceptional effectiveness.
“It’s extraordinary,” Fawcett said. “It’s almost at the level of what we want from measles, which is %%% effective.”
Continue reading
